Progress in Polymeric Nano-Medicines for Theranostic Cancer Treatment

Polymers
Imran AliJung-Chih Chen

Abstract

Cancer is a life-threatening disease killing millions of people globally. Among various medical treatments, nano-medicines are gaining importance continuously. Many nanocarriers have been developed for treatment, but polymerically-based ones are acquiring importance due to their targeting capabilities, biodegradability, biocompatibility, capacity for drug loading and long blood circulation time. The present article describes progress in polymeric nano-medicines for theranostic cancer treatment, which includes cancer diagnosis and treatment in a single dosage form. The article covers the applications of natural and synthetic polymers in cancer diagnosis and treatment. Efforts were also made to discuss the merits and demerits of such polymers; the status of approved nano-medicines; and future perspectives.

References

Feb 1, 1980·Journal of Pharmaceutical Sciences·P CouvreurP Speiser
Jan 1, 1994·Clinical Oncology : a Journal of the Royal College of Radiologists·N D JamesJ S Stewart
Jan 21, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·K KataokaG S Kwon
Feb 13, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·K S SoppimathW E Rudzinski
Jun 8, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·S C KimM H Seo
Dec 14, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S R Johnston, M E Gore
Jun 8, 2002·Breast Cancer Research : BCR·John W Park
Mar 12, 2003·Advanced Drug Delivery Reviews·Jayanth Panyam, Vinod Labhasetwar
Apr 30, 2003·Proceedings of the National Academy of Sciences of the United States of America·Vladimir P TorchilinBrigitte Papahadjopoulos-Sternberg
Jan 18, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Zhong-Gao GaoNatalya Rapoport
Mar 19, 2005·Drug Development and Industrial Pharmacy·Sydney UgwuImran Ahmad
Jul 20, 2005·Molecular Pharmaceutics·Michael F NeermanEric E Simanek
Nov 25, 2005·Advanced Drug Delivery Reviews·Sönke Svenson, Donald A Tomalia
May 26, 2006·Expert Opinion on Pharmacotherapy·William J Gradishar
Jul 13, 2006·Journal of Separation Science·Imran Ali, Hassan Y Aboul-Enein
Jul 19, 2006·Cancer Chemotherapy and Pharmacology·Tomislav DragovichAxel Hoos
Jul 25, 2006·Expert Opinion on Pharmacotherapy·Maurie Markman
Sep 2, 2006·Biological & Pharmaceutical Bulletin·Manju RawatSwarnlata Saraf
Dec 16, 2006·Current Pharmaceutical Design·Amitava MitraHamidreza Ghandehari
Mar 30, 2007·Chirality·Imran AliBhavtosh Sharma
Jun 16, 2007·Journal of the American Chemical Society·Rodney P FeazellStephen J Lippard
Jul 24, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kyeongsoon ParkIck Chan Kwon
May 2, 2008·Advanced Drug Delivery Reviews·Jesse B Wolinsky, Mark W Grinstaff
Jul 26, 2008·Nature Nanotechnology·Dan PeerRobert Langer
Dec 17, 2008·Journal of the American Chemical Society·Jih Ru HwuDar-Bin Shieh
Apr 1, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kouichi ShiraishiMasayuki Yokoyama
May 21, 2009·Molecular Pharmaceutics·Lisa M KaminskasChristopher J H Porter

❮ Previous
Next ❯

Methods Mentioned

BETA
neutron capture therapy
imaging techniques
xenograft
acetylation
MDA
antisense oligonucleotides
fluorescence imaging
pharmacotherapy

Software Mentioned

Theranostics
MCE
GLOBOCAN

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.